A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

Clinical trial NCT07595653 · RECRUITING

Trial details

NCT number: NCT07595653
Sponsor: argenx
Status: RECRUITING
Study type: OBSERVATIONAL

Generalized Myasthenia Gravis (gMG)gMG

Start date: 2026-02-25
Primary completion: 2027-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.